We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Genetically Engineered Zika Virus Slows Tumor Growth in Model

By LabMedica International staff writers
Posted on 11 Oct 2018
Print article
Image: A digitally colorized transmission electron microscopic (TEM) image of Zika virus. Virus particles, here colored blue, are 40 nanometers in diameter, with an outer envelope and an inner dense core (Photo courtesy of the CDC).
Image: A digitally colorized transmission electron microscopic (TEM) image of Zika virus. Virus particles, here colored blue, are 40 nanometers in diameter, with an outer envelope and an inner dense core (Photo courtesy of the CDC).
Injecting mice carrying human glioblastoma tumors with modified Zika virus was shown to significantly reduce intracerebral tumor growth and prolong animal survival.

Glioblastoma is the most common primary tumor of the central nervous system and is almost always fatal. The aggressive invasion of glioblastoma cells into the surrounding normal brain makes complete surgical removal impossible, significantly increases resistance to the standard therapy regimen, and virtually assures tumor recurrence. Treatment of glioblastoma usually comprises surgical removal of the tumor followed by radiation treatment and chemotherapy using the drug temozolomide (TMZ). These treatments usually fail, mainly due to the presence of a cell subpopulation called glioma stem cells (GSCs), which are resistant to radiation and chemotherapy and are capable of self-renewal and tumor generation.

Previous studies had shown that Zika virus (ZIKV) attacked and killed GSCs grown in culture and in a mouse model of glioblastoma. To expand the scope of these earlier findings, investigators at the University of Texas Medical Branch (Galveston, USA) and Chinese collaborators developed a genetically modified live attenuated ZIKV vaccine (ZIKV-LAV) that contained a 10-nucleotide deletion in the 3′ untranslated region (3′UTR) of the viral genome. This method for engineering ZIKV eliminated its virulence but maintained its oncolytic activity against GBM.

The goals of this study were to (i) profile the safety of ZIKV-LAV for intracerebral injection, (ii) evaluate the in vivo efficacy of ZIKV-LAV against GBM in a patient-derived GSC orthotopic mouse model, and (iii) define the oncolytic mechanism of ZIKV-LAV during GBM treatment.

The investigators reported in the September 18, 2018, online edition of the journal mBio that intracerebral injection of ZIKV-LAV into mice caused no neurological symptoms or behavioral abnormalities. ZIKV-LAV significantly reduced intracerebral tumor growth and prolonged animal survival by selectively killing GSCs within the tumor. Mechanistically, ZIKV infection elicited antiviral immunity, inflammation, and GSC apoptosis.

"During the Zika epidemic, we learned that the virus preferentially infects neural progenitor cells in the fetus, and causes the devastating microcephaly seen in babies born to infected mothers," said contributing author Dr. Pei-Yong Shi, professor of human genetics at the University of Texas Medical Branch. "As a virologist, I see that we should take advantage of the "bad' side of viruses. They should have a role to play in cancer treatment."

Related Links:
University of Texas Medical Branch

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.